---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000439"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:58:30.045256+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Prelude Therapeutics files corporate presentation; no specific new details provided

## Summary
- Prelude Therapeutics made a corporate presentation available to investors on January 9, 2023.
- The presentation was furnished under Regulation FD but its substantive content was not disclosed.
- No changes to revenue, EPS, pipeline status, or corporate strategy were announced.
- The filing does not contain any new material information beyond the existence of the presentation.

## SEC filing metadata
- accession: 0000950170-23-000439
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/0000950170-23-000439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/prld-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000439
- JSON: https://secwatch.observer/filing/0000950170-23-000439.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.